Citation Number
2
Views
13
Downloands
1
SARS-CoV-2 adı verilen yeni koronavirüs ilk defa 29 Aralık 2019’da, Çin’in Wuhan şehrindeki deniz ürünleri ve canlı hayvan satan bir markette çalışan ve bu marketi ziyaret eden çok sayıda kişide pnömoni bulgularının tespit edilmesiyle gündeme gelmiştir. Bulaşıcılığının çok yüksek olduğu bilinen bu virüs ağız, burun ya da göz gibi mukozal yüzeylerden vücuda girebilmektedir. Aynı şekilde virüsün yayılımının da damlacık yoluyla ve sekresyonlarla olduğu bilinmektedir. Virüse karşı henüz geliştirilmiş bir aşı ya da kanıtlanmış antiviral bir tedavi mevcut değildir. Koronavirüslerin de dahil olduğu bir grup viral enfeksiyon ajanının hem sistemik hem oküler enfeksiyona sebep olduğu bilinmektedir. Oftalmoloji muayeneleri sırasında hastanın gözyaşı ile konjonktivasına temas olabildiği ve çok yakın çalışıldığından bulaş açısından hem hasta hem göz hekimi için risk taşır. Bu derlemede SARS-CoV-2 ile konjonktivit ilişkisi ve covid – 19 testi pozitif olan hastaların göz muayenesi sırasındaki bulaş riski literatür eşliğinde irdelenecektir.
The new SARS-CoV-2 virus first appeared on December 29, 2019 with the detection of pneumonia findings in a large number of people who work at a market in Wuhan, China, which sells seafood and livestock and visits the market. This virus, known to be very infectious, can enter the body through the mucous surfaces such as the mouth, nose or eye. It is also known that the spread of the virus is through drops and secretions. There is no vaccination or proven antiviral treatment against the virus yet. A group of viral infectious agents, including coronavirus, is known to cause both systemic and ocular infections. During the ophthalmology examinations, the patient may be in contact with the conjunctive with tears and because it is studied very closely, it is a risk for both the patient and the eye doctor from the point of view of infection. In this collection, the conjunctivitis relationship with SARS-CoV-2 and covid-19 tests are positive in patients with eye examination will be accompanied by the literature of the risk of infection.
The new coronavirus, called SARS-CoV-2, came for the first time on December 29, 2019 by detecting signs of pneumonia in a large number of people working and visiting a market selling seafood and live animals in Wuhan, China. This virus, known to be very infectious, can enter the body through mucosal surfaces such as mouth, nose or eyes. Likewise, the spread of the virus is known to be through droplets and secretions. There is no vaccine or proven antiviral treatment for the virus yet. A group of viral infectious agents, including coronaviruses, are known to cause both systemic and ocular infections. During the ophthalmology exams, the patient's tear and conjunctiva can be contacted, and because it has been studied very closely, it poses a risk to both the patient and the ophthalmologist in terms of transmission. In this review, the relationship between SARS-CoV-2 and conjunctivitis and the risk of transmission during eye examination of patients with positive covid - 19 test will be examined in the light of the literature.
Field : Sağlık Bilimleri
Journal Type : Uluslararası
Article Detail 
Citation Owners
Similar Articles
Download PDF
Journal Information
Listen Paper
Print This Page
Share
Mendeley
